|
Volumn 12, Issue 2, 2000, Pages 110-115
|
High dose cytarabine or transplantation for consolidation of younger patients with acute myeloid leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTARABINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ALLOGENIC BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG MEGADOSE;
HUMAN;
PRIORITY JOURNAL;
REVIEW;
ADOLESCENT;
ADULT;
ANTIMETABOLITES, ANTINEOPLASTIC;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIALS;
CYTARABINE;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LEUKEMIA, NONLYMPHOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
PROGNOSIS;
|
EID: 0034508008
PISSN: 10408746
EISSN: None
Source Type: Journal
DOI: 10.1097/00001622-200003000-00002 Document Type: Review |
Times cited : (6)
|
References (26)
|